Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 4,309 | 0 | 23,067 | 14,658 | 9,985 |
| Cost of Goods | N/A | N/A | 11,214 | 5,010 | 12,467 |
| Gross Profit | 4,309 | N/A | 11,853 | 9,648 | -2,482 |
| Operating Expenses | 31,803 | 40,962 | 63,732 | 63,607 | 136,758 |
| Operating Income | -27,494 | -40,962 | -51,665 | -53,949 | -138,773 |
| Other Income | -3,429 | -2,102 | -2,024 | -1,944 | -810 |
| Pre-tax Income | -30,923 | -43,064 | -53,689 | -55,893 | -139,583 |
| Income Tax | N/A | N/A | N/A | -23,301 | -19,692 |
| Net Income Continuous | -30,923 | -43,064 | -53,689 | -32,592 | -119,891 |
| Net Income Discontinuous | 13,173 | 2,616 | N/A | 39,565 | 7,476 |
| Net Income | $-17,750 | $-40,448 | $-53,689 | $6,973 | $-112,415 |
| EPS Basic Total Ops | -5.23 | -13.86 | -2.39 | 0.33 | -5.55 |
| EPS Basic Continuous Ops | -9.12 | -14.76 | -2.39 | -1.53 | -5.92 |
| EPS Basic Discontinuous Ops | 3.88 | 0.90 | N/A | 1.86 | 0.37 |
| EPS Diluted Total Ops | -5.23 | -13.86 | -2.39 | 0.33 | -5.55 |
| EPS Diluted Continuous Ops | -9.12 | -14.76 | -2.39 | -1.53 | -5.92 |
| EPS Diluted Discontinuous Ops | 3.88 | 0.90 | N/A | 1.86 | 0.37 |
| EBITDA(a) | $-26,088 | $-38,727 | $-49,275 | $-50,822 | $-135,411 |